熱門資訊> 正文
STAAR外科授权5000万美元股票回购
2026-09-25 04:05
- STAAR Surgical’s (STAA) board authorized a share repurchase program of up to $50M of its outstanding common stock.
- The program is expected to run for 12 months.
- STAAR plans to fund repurchases with organic free cash flow and cash on hand, with no outstanding debt and $181.5M in cash, equivalents, and investments as of July 3, 2026.
- The company had ~50.1M shares outstanding as of August 7, 2026, making the authorized buyback equivalent to up to roughly 5% of shares outstanding if fully utilized.
More on STAAR Surgical
- STAAR Surgical Company (STAA) Q2 2026 Earnings Call Transcript
- STAAR Surgical's Punishment For Opacity Is Just
- Staar surgical plans to end 2026 with well over $200M in cash while shifting 100% of China supply to Switzerland
- STAAR Surgical Non-GAAP EPS of $0.39 beats by $0.16, revenue of $93.5M beats by $2.95M
- Seeking Alpha’s Quant Rating on STAAR Surgical
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。